The purpose of SMART is to monitor the in vitro susceptibility of clinical bacterial isolates to antimicrobials in intra-abdominal infections worldwide. This Web site is intended for health care professionals outside of the US only.

SMART monitors longitudinal susceptibility patterns (based on bacterial population MICs) among target organisms in the regions of Asia/Pacific (A/P), Latin America (LA), Middle East/Africa (ME/A), North America (NA), and Europe (EU).

SMART provides important information about changes in the spectrum of microbial pathogens and trends in the antimicrobial resistance patterns in nosocomial and community-acquired intra-abdominal infections. Continued monitoring of antimicrobial resistance patterns in hospitals is essential to guide effective empiric therapy.

SMART (Study for Monitoring Antimicrobial Resistance Trends)
New User? Click here.

Log In
 
 
Forgot your password?

Merck & Co., Inc., Whitehouse Station, NJ, USA, is pleased to provide this Web site for health care professionals. By registering, you will be able to access resources regarding SMART. The information you provide when you register and use this site will be available to Merck & Co., Inc., and its affiliates globally, known as MSD or Merck Sharp & Dohme, and those working on behalf of Merck & Co., Inc., and its affiliates to enable you to access this Web site and to contact you in the future, including via e-mail, regarding SMART and updates to this Web site.

For additional information about how Merck & Co., Inc., and its affiliates use and protect information about health care professionals, please read our Internet Privacy Policy and Global Data Practices Notice for Health Care Professionals.
IVZ-2009-W-1293802-W